Open AccessHeart Failure Drug Utilization Patterns for Medicaid Patients Before and After a Heart Failure‐Related Hospitalization
Author(s) -
Howard Patricia A.,
Shireman Theresa I.
Publication year - 2005
Publication title -
congestive heart failure
Language(s) - English
Resource type - Journals
eISSN - 1751-7133
pISSN - 1527-5299
DOI - 10.1111/j.1527-5299.2005.03872.x
Subject(s) - medicine , medicaid , digoxin , heart failure , retrospective cohort study , cohort , angiotensin receptor blockers , angiotensin converting enzyme , cardiology , blood pressure , health care , economics , economic growth
The authors examined heart failure (HF) drug utilization patterns in Medicaid patients before and after a HF‐related hospitalization. This was a retrospective claims analysis of Kansas Medicaid beneficiaries hospitalized for HF between July 1, 2000, and March 31, 2001. HF drugs were tracked 6 months prior and 6 months following the admission. Angiotensin‐converting enzyme (ACE) inhibitor doses were compared with target ranges. The cohort of 135 patients had a mean age of 53.6 years and was predominantly female (66.7%) and Caucasian (70.4%) with a high prevalence of cardiovascular comorbidities. Before hospitalization, less than one third of patients were receiving ACE inhibitors, angiotensin receptor blockers, β blockers, digoxin, or vasodilators. Following hospitalization, increased utilization was observed for β blockers, digoxin, and angiotensin receptor blockers, but overall usage remained low. ACE inhibitors and vasodilator use remained constant. ACE‐inhibitor doses were below target ranges before and after hospitalization. In this Medicaid cohort, HF‐related hospitalizations did not lead to improved HF therapy.